4
1
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15396 |
GN44028
N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
HIF | Angiogenesis; Chromatin/Epigenetic |
GN44028 (N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine) 是缺氧诱导因子(HIF)-1的有效抑制剂,其 IC50=14 nM。它可以抑制低氧诱导的 HIF-1α 的转录特性,但不抑制 HIF-1α mRNA 的表达,HIF-1α 蛋白的累积或HIF-1α/HIF-1β 的异缘二聚化。 | |||
T80626 |
VGSCs-IN-1
|
Sodium Channel | Membrane transporter/Ion channel |
VGSCs-IN-1 是一种有效的 VGSC 抑制剂,是一种 Riluzole 的 2-哌嗪类似物,在Nav1.4上展现出良好的阻断活性。VGSCs-IN-1可用于研究细胞兴奋性障碍。 | |||
T21842 |
2-fluoro Palmitic Acid
|
Others | Others |
2-Fluoropalmitic acid, 是一种酰基辅酶 A 合成酶抑制剂,是一种候选的抗神经胶质瘤的药物。 2-Fluoropalmitic acid 抑制胶质瘤干细胞 (GSC) 活力和干细胞样表型。 2-Fluoropalmitic acid 还抑制神经胶质瘤细胞系的增殖和侵袭。 | |||
T60661 |
CP681301
|
Others | Others |
CP681301 是CDK5的有效抑制剂,具有抗增殖活性。CP681301 在果蝇中表现出抗肿瘤活性。CP681301 降低神经胶质瘤干细胞中 CD133、OLIG2、SOX2、KI67、pCDK5 蛋白水平的表达。CP681301 减少小鼠胶质瘤异种移植物的自我更新。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5784 |
Topotecan
NSC 609669,拓扑替康,SKF 104864A |
Topoisomerase; Autophagy | Autophagy; DNA Damage/DNA Repair |
Topotecan (NSC-609669) 是一种拓扑异构酶 I 抑制剂,通过抑制 DNA 拓扑异构酶起抗肿瘤作用,可用于治疗卵巢癌。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00732 |
WISP1/CCN4 Protein, Mouse, Recombinant (His)
ELM-1,WISP1tc,WISP1c,CCN4,WISP-1,WISP1i |
Mouse | HEK293 Cells |
The interplay between glioma stem cells (GSCs) and the tumor microenvironment plays crucial roles in promoting malignant growth of glioblastoma (GBM), the most lethal brain tumor. WISP1 is preferentially expressed and secreted by GSCs. Silencing WISP1 markedly disrupts GSC maintenance, reduces tumor-supportive TAMs (M2), and potently inhibits GBM growth. WISP1 signals through Integrin α6β1-Akt to maintain GSCs by an autocrine mechanism and M2 TAMs through a paracrine manner. |